SkinDNA™ takes the guesswork out of skincare by using science to identify the most suitable skin ingredients and treatment modalities based on our DNA. The genetic analysis targets 16 genetic markers (SNPs) in 5 categories associated with skin aging: Firmness & Elasticity, Wrinkling, Sun Damage & Pigmentation, Free Radical Damage, and Sensitivity & Inflammation. SkinDNA provides a phenomenal scientific tool in suggesting topical ingredients, internal supplements, and treatment modalities by effectively targeting our genetic blueprint.
Leader Life Sciences is associated with industry leaders to ensure offering outstanding scientific solutions and technologies. We value our relationship with our global partners and ensure strategic collaborations to drive profitable growth.
CELLINK is the leading bio-convergence company and a global provider of technologies, products and services to create, understand and master biology. With a focus on the areas of bioprinting, biosciences and industrial solutions, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. CELLINK’s products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 60 countries, and have been cited in more than 700 publications. CELLINK is creating the future of medicine. Cellink is providing an enormous platform of technologies to enable researchers to 3D-print organs and tissue that solves the crisis of national transplant waiting list in addition to other applications that span industries, from pharmaceutical to cosmetic.
Discover Echo has revolutionized the market by offering hybrid automated microscopes with greater versatility than other systems on the market. Discover Echo has significantly improved the usability of their microscopes by replacing traditional eyepieces with ultra-high-resolution touchscreen displays and offering a unique software app that advances the workflow of acquiring, sharing, and analyzing images. The revolver is two microscopes in one. It provides a fully capable inverted research instrument, and a fully capable upright microscope, into one device. Their products are widely used in the field of tissue engineering, cell line development, multi-omics, and diagnostics. Discover Echo’s revolutionary microscopy technology and disruptive product line further complements the concept of bioconvergence and related products. They are combining a strong, purpose-driven growth agenda with trailblazing technologies for the sake of improving health all around the world.
Allentown, Inc. is a leading global life science solutions provider for over 50 years. They play a vital role in heroic research aimed at serving customers worldwide in saving lives. The company specializes in the production of housing solutions for the laboratory animal science community. Allentown has gained enough trust from the biomedical research community by providing critical services with integrity and care. The originator of 14 patents, Allentown works at developing innovative solutions and creating an environment where more research can be conducted, and more progress can be made. The company’s wide range of high-end products involves precision-engineered, reliable equipment with high durability that is efficient, safe, accurate and humane. Their systems are known for their efficiency, performance, and dependability within a clinical environment. They continue to aspire to be not just a supplier of vital equipment, but a trusted partner in every step of the research process.
Haier BioMedical is a part of Haier Group Company which is highly ranked as one of the key global manufacturers of durable goods. Haier Biomedical designs and manufactures equipment for laboratory and medical applications for the global market. Haier Biomedical has been developing and pioneering smarter, greener, and cleaner technologies to reduce the energy and impact of its equipment within the lab. Their products are designed to enable scientific researchers and clinicians across the globe to perform research projects, produce pharmaceutical products and treat patients. Haier Biomedicals’ portfolio includes ultra-low temperature freezers, blood banks, pharmacy refrigerators, ice lined vaccine refrigerators, laboratory freezers, biosafety cabinets, and equipment for laboratory and medical applications.
Ratiolab® has been serving the scientific community since 1975 by developing and producing premium plastic products for the laboratory and medicine such as pipet tips, cuvettes, and micro test plates. Scientists and researchers from various fields globally appreciate and trust Ratiolab’s products for facilitating high levels of efficiency and innovation in their workflow.
For more than 40 years, Ratiolab has been characterized with supplying everything that facilitates daily work routines, increases accuracy, and improves process safety in the efforts of increasing efficiency in laboratories worldwide.
MVE Biological Solutions is the leading global manufacturer of vacuum insulated products and cryogenic systems. Over 50 years, MVE Biological Solutions set the standard for storage of biological materials at low temperatures. MVE is the preferred brand for cryogenic equipment in a variety of application areas including bio-pharma cell and gene therapies, storage of cord blood and stem cells, medical research facilities, government institutions, IVF centers, hospitals and clinics, and animal husbandry and livestock.
Bringing cutting edge technology in the immuno-diagnostics market, PCL was founded based on original technology which we co-developed with German-based Scienion AG. Reviewed by the nationally designated research laboratories of over thirty countries across the world where it has been registered and patented. Since its establishment in 2008, they have succeeded in commercializing the world’s first high-risk viral blood screening multiplex immunodiagnostic product based on the original technology.
– The digital pathology company that believes in providing clinical pathologists, researchers, and universities, with efficient solutions that will enable quick and accurate results. Committing their entire resources to the new digital revolution, they are a proud team with exclusive focus on digital pathology. The patient care is the core of the company, to provide ultimate experience for the patient and receive personalized treatment.
A leader in the field of life science industry, they specialize in developing, producing and selling products and services for laboratories around the world. Used broadly in academic and commercial research laboratories along with clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance.
Since the founders, Gustav and Karl Ohaus formed the company in 1907, OHAUS has been creating safe, precise, and trustworthy scales, analytical instruments, and laboratory equipment for the research community. Developed alongside the sectors they serve, OHAUS ensured that their solutions serve future needs as well. The basic concepts of Trust, Agility, Ingenuity, and Commitment is the OHAUS Advantage.
Any living species’ biological systems are complicated and unique. As a result, the apparatus and reagents required to conduct the research must be specialized. MP Biomedicals has established itself as a trustworthy provider of a diverse range of life science goods and services. They also give unique solutions for your needs on demand.
For market efficiency and competitiveness, having a digitized lab is a prerequisite. Holo4Lab specializes in these digital transformation efforts. Combining the benefits of mixed reality with data integration into your existing systems they create an experience for lab professionals. Supporting lab personnel in their everyday task, providing step-by-step instructions through the task list, sample management, and automatically assigning appropriate methods and procedures are some of the solutions offered.
By pushing digitization in healthcare, Holo4Med provides innovative solutions for the medical industry to save lives. Their platform MediSMART Telemedicine, which allows immediate access to a patient’s medical record, can be used in a variety of settings, including at-home treatment, laboratories, clinics, medical universities, and military hospitals. Holo4Med is changing the way healthcare providers communicate with patients by allowing them to communicate more efficiently and having access to their whole patient data at their fingertips.
An extensive ‘patient-specific’ solution provider that primarily focuses on providing personalization for treatment. The core aim is to aid surgical practices by simplifying and customizing the operative planning and procedures, thereby improving patient recovery quality.
This collaboration will improve access to a wide range of disease-related antibodies that DBS has optimized for high-quality staining in immunohistochemical (IHC) applications, as well as a wide range of IHC ancillaries and superior automated IHC platforms. In addition, the pathology community of the region can use this technology to further their research on fatal diseases like Cancer.
With a strong conviction toward preventive Healthcare, Randox strives to provide accurate and accessible diagnostics. 70% of all medical decisions are made on laboratory results; therefore, a well-equipped lab is what our collaboration aims to provide for advanced patient care.
The collaboration with Curetis equips clinicians with diagnostic solutions that would make them more effective and combat severe infectious diseases. Curetis received FDA approval for the Unyvero LRT Panel for tracheal aspirate samples in 2018, followed by FDA approval for the Unyvero LRT BAL for bronchoalveolar lavage samples in 2019. Hospitals can use the Unyvero LRT and LRT BAL to diagnose serious Pneumonia infections and target effective antibiotic treatment using syndromic testing. Faster, more targeted treatment results in lower mortality, lower healthcare costs, and better antibiotic utilization.